| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.82B | 21.43B | 21.02B | 19.56B | 18.13B | 17.17B |
| Gross Profit | 7.80B | 7.50B | 7.38B | 6.70B | 7.08B | 6.78B |
| EBITDA | 996.75M | 852.00M | 1.76B | 1.10B | 1.88B | 1.65B |
| Net Income | 124.00M | 13.00M | 835.00M | 448.00M | 965.00M | 872.00M |
Balance Sheet | ||||||
| Total Assets | 26.10B | 25.90B | 26.43B | 25.34B | 24.75B | 23.90B |
| Cash, Cash Equivalents and Short-Term Investments | 7.54B | 7.55B | 7.18B | 6.44B | 6.80B | 7.00B |
| Total Debt | 535.00M | 494.00M | 582.00M | 682.00M | 773.00M | 1.54B |
| Total Liabilities | 7.21B | 6.89B | 7.28B | 7.09B | 6.79B | 6.69B |
| Stockholders Equity | 18.89B | 19.02B | 19.15B | 18.25B | 17.96B | 17.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 762.00M | 1.04B | -105.00M | 1.08B | 19.00M |
| Operating Cash Flow | 0.00 | 1.13B | 1.49B | 341.00M | 1.73B | 1.66B |
| Investing Cash Flow | 0.00 | -474.00M | -468.00M | -450.00M | -666.00M | -1.67B |
| Financing Cash Flow | 0.00 | -347.00M | -302.00M | -316.00M | -1.30B | -378.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥42.72B | 10.59 | ― | 3.59% | 6.91% | 13.17% | |
77 Outperform | ¥52.96B | 18.24 | ― | 3.74% | 3.70% | 12.26% | |
66 Neutral | ¥123.62B | 35.48 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥141.07B | 11.40 | 12.89% | 3.40% | 2.98% | 41.11% | |
65 Neutral | ¥10.44B | 45.49 | ― | 3.73% | 3.06% | -75.19% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥6.23B | 8.23 | ― | 4.13% | 2.76% | -10.23% |